Out of Academics: Education, Entrepreneurship and Enterprise.

The author started a niche biotech company in 1985 called Flexcell® to distribute an enabling technology, mechanobiology devices, to the field. He was

Read more

Advancing Cancer Survivorship in a Country with 1.35 Billion People: The China Lymphoma Project.

Rates of lymphoma are rising rapidly and lymphoma is now the ninth most common cancer among Chinese males. The China

Read more

The challenge of selecting protein kinase assays for lead discovery optimization.

BACKGROUND: Protein kinases represent one of the most promising groups of drug targets owing to their involvement in such pathological

Read more